CRP and hyperuricemia: Mono-isobutyl phthalate (MiBP), a metabolite of DiBP, is not only associated with the occurrence of diabetes and hyperuricemia but also with elevated C-reactive protein (CRP) levels, a marker of systemic inflammation (19).